Market Research Report New Study provides Vaginal Atrophy Global Pipeline | Page 2

Table of Contents
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Vaginal Atrophy (Atrophic Vaginitis) Overview 6
Therapeutics Development 7
Pipeline Products for Vaginal Atrophy (Atrophic Vaginitis) - Overview 7
Vaginal Atrophy (Atrophic Vaginitis) - Therapeutics under Development by Companies 8
Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Products Glance 9
Late Stage Products 9
Clinical Stage Products 10
Early Stage Products 11
Vaginal Atrophy (Atrophic Vaginitis) - Products under Development by Companies 12
Vaginal Atrophy (Atrophic Vaginitis) - Companies Involved in Therapeutics Development 13
Allergan Plc 13
EndoCeutics, Inc. 14
Foamix Pharmaceuticals Ltd. 15
Ligand Pharmaceuticals, Inc. 16
Mithra Pharmaceuticals S.A. 17
PEPTONIC medical AB 18
Vaginal Atrophy (Atrophic Vaginitis) - Therapeutics Assessment 19
Assessment by Monotherapy Products 19
Assessment by Target 20
Assessment by Mechanism of Action 22
Assessment by Route of Administration 24
Assessment by Molecule Type 26
Drug Profiles 28
Estetrol - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Estradiol hemihydrate - Drug Profile 31
Request for Free Sample Report
Product Description 31
Mechanism Of Action 31
R&D Progress 31
lasofoxifene tartrate - Drug Profile 32
Product Description 32
Mechanism Of Action 32